ロード中...
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability
BRCA1 plays a critical role in the regulation of homologous recombination (HR)-mediated DNA double-strand break repair. BRCA1-deficient cancers have evolved to tolerate loss of BRCA1 function. This renders them vulnerable to agents, such as PARP inhibitors, that are conditionally ‘synthetic lethal...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3030974/ https://ncbi.nlm.nih.gov/pubmed/21278454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jmcb/mjq055 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|